PRIMARY OR SECONDARY INJURY of renal endothelium occurs in kidney diseases such as thrombotic microangiopathy, vasculitis, lupus nephritis, and glomerulonephritis. The balance between endothelial cell injury and repair is considered to be crucial for the further time course of disease resulting in recovery or chronic progression (21) . In 1997, Asahara (2) provided the first evidence that putative endothelial cell progenitors incorporate into sites of postnatal angiogenesis. This landmark finding called the prevalent theory of plain endothelial self-renewal into question. Incorporation of extrarenalderived cells into the kidney endothelium was subsequently demonstrated in patients with kidney allograft rejection, but results were highly variable and general conclusions for acute and chronic kidney diseases could not be drawn (10, 11, 19, 25) . To study this issue systematically, animal models of experimental kidney injury were combined mainly with bone marrow transplantation to allow discrimination of extrarenal from intrarenal-derived endothelial cell replacement. A highly variable percentage of endothelial chimerism was documented in kidney injury models. Contradicting results ranged from 30% of extrarenal-derived endothelium to the detection of no endothelial chimerism at all (9, 12, 13, 18, 22, 23, 27) . Hence, the proportion of incorporated endothelial cells from exogenous, nonrenal sources in kidney diseases is still controversial. It is unknown if there are quantitative differences that account for progression or healing of kidney diseases. Thus the goal of our study was the quantification of incorporated endothelial cells from extrarenal sources in both an acute and reversible, endothelial cell-specific nephritis model (GEN model) and a complex, chronic progressive model of kidney endothelial injury, the 5/6 nephrectomy model (5/6 Nx model; Refs. 15, 16) . Syngeneic rat kidney transplantation, in which Fischer F-344wt (wild type) rat kidney grafts were transplanted into R26-hPAP (human placental alkaline phosphatase) transgenic Fischer F-344 recipient rats, was combined with either antiglomerular endothelial cell antibody perfusion (GEN group) or two-thirds renal mass reduction (5/6 Nx group) of the kidney graft. Despite very severe injury, the endothelium of GEN rats recovered 4 wk after model induction, whereas the endothelium of 5/6 Nx rats progressively decreased until death at week 14. Analysis of endothelial hPAP-chimerism (4 and 14 wk after injury, respectively) revealed that, independently of disease outcome, extrarenal-derived cells were only marginally incorporated into kidney endothelium in either model.
MATERIALS AND METHODS

Experimental design.
The animal studies were performed in accordance with the internal animal review board (Regierung von Mittelfranken: 54-2531.31-15/03). Thirty-six Fischer F-344wt rat kidney grafts (hPAP negative) were transplanted into R26-hPAP transgenic Fischer F-344 recipient rats to allow histological tracing of recipientderived cells in the donor kidneys (Fig. 1 ). Rat kidney transplantation was performed as described by Vogelbacher et al. (26) .
In 14 cases, acute endothelial injury was induced by kidney graft perfusion with 0.2 ml of saline followed by 80 mg/kg body wt of antiglomerular endothelial cell antibody (GEN group; Ref. 16 ). Kidneys were perfused ex vivo via the renal artery by slow and gentle fluid injection with a 1-ml syringe (BD Micro-Fine, San Diego, CA). Appropriate antibody dilution had been tested in pilot experiments to reach maximal endothelial damage. One recipient kidney was removed and one recipient kidney remained as an assist organ to prevent death from acute kidney injury. In 12 corresponding controls, kidney grafts were perfused just with saline where the volume of saline was adjusted to the total fluid volume that was used for perfusion in the GEN group. Kidney perfusion was performed in the same way as in the GEN group indicating that also the pressure of perfusion was equal in both groups. Seven GEN rats and six controls were killed at day 3 for histological assessment of endothelial damage in the grafts (GEN day 3, Fig. 1A ). The remaining seven GEN rats and six controls underwent explantation of the assist kidney after 3 wk to prove sufficient functional recovery of GEN-treated grafts. At week 4 (GEN week 4, Fig. 1B ), animals were killed and grafts were removed for histology. Blood samples were collected for analysis of serum creatinine.
In another five cases, kidney transplantation was combined with 5/6 nephrectomy to induce chronic endothelial injury (5/6 Nx group, Fig.  1C) . Two of the three branches of the graft artery were ligated immediately before explantation from the donor animal. Both kidneys of the graft recipient were removed. In five control cases, kidney transplantation was performed with sham handling of the graft and explantation of both recipient kidneys. The 5/6 Nx rats and controls were killed after 14 wk (5/6 Nx week 14) , and grafts were removed for histology. Blood samples were collected for analysis of serum creatinine.
As a control experiment, we studied endothelial hPAP expression during experimental kidney injury in three GEN-induced R26-hPAP transgenic Fischer F-344 rat donor kidneys that were transplanted into R26-hPAP transgenic Fischer F-344 recipient rats (positive controls). Animals were killed after 4 wk, and endothelial hPAP expression was compared between the GEN-induced kidney grafts and not-induced R26-hPAP transgenic Fischer F-344 rat kidneys by RECA-1 and hPAP double immunostaining.
Since recipient-derived endothelium most likely derives from the bone marrow, the degree of hPAP expression was analyzed in bone marrow smears of two R26-hPAP transgenic Fischer F-344 rats and two Fischer F-344wt rats. The femoral medulla was collected immediately after death, and bone marrow smears were performed by push smear technique.
Immunohistochemistry. Kidney tissue for light microscopy and periodic acid-Schiff (PAS) staining was fixed in Carnoy's solution and embedded in paraffin. Kidney tissue for light microscopy and indirect immunoperoxidase staining, nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) staining, and also immunofluorescence microscopy was fixed in zinc fixative solution (BD Pharmingen, San Diego, CA) and embedded in paraffin. Threemicrometer paraffin sections were used for staining procedures. Bone Fig. 1 . Experimental setup. Kidneys were transplanted from F-344wt (wild type) rats (white) to R26-hPAP (human placental alkaline phosphatase) transgenic Fischer F-344 rats (gray). A [antiglomerular endothelial cell (GEN), day 3]: the GEN model was induced by kidney graft perfusion with anti-GEN antibody (n ϭ 7). Control grafts were perfused only with saline solution (n ϭ 6). Animals were killed after 3 days, and kidneys were removed for histology. B (GEN week 4): the GEN model was induced by kidney graft perfusion with anti-GEN antibody (n ϭ 7). Control grafts were perfused only with saline solution (n ϭ 6). The remaining recipient kidney (assist organ) was removed after 3 wk in both groups. At week 4, animals were killed. Serum creatinine was measured ([Cr]). Kidney grafts were removed for histology. C [5/6 nephrectomy (5/6) Nx week 14]: the 5/6 Nx model was induced by two-thirds nephrectomy of the graft and explantation of both recipient kidneys (n ϭ 5). Control grafts were transplanted sham treated, and both recipient kidneys were removed (n ϭ 5). Animals were killed after 14 wk. Serum creatinine was measured ([Cr]). Kidney grafts were removed for histology. marrow smears were air dried and stained within 1 h. PAS and indirect immunoperoxidase staining were performed as described by IruelaArispe et al. (8) . Indirect immunoperoxidase staining for rat endothelium was performed with a murine monoclonal IgG 1 antibody against RECA-1 (AbD Serotec, Oxford, UK). Changes in endothelium expression patterns were confirmed by indirect immunoperoxidase staining of tissue sections with JG-12 (Bender Medsystems, Vienna, Austria), a murine IgG 1 monoclonal antibody specific for rat aminopeptidase P. Negative controls for immunostaining included either deleting the primary antibody or substitution of the primary antibody with equivalent concentrations of an irrelevant murine monoclonal antibody. To identify recipient-derived cells, kidney tissue was either enzymatically reacted for hPAP activity using NBT/BCIP (toluidine salt) or stained with specific anti-hPAP antibody for immunofluorescence analysis. For enzymatic treatment, kidney sections and bone marrow smears were washed with TBS, heated for 1 h in TBS up to 60°C (to denature endogenous alkaline phosphatase, leaving only the heat-stable hPAP enzyme active), and reacted with substrate NBT/ BCIP (Roche, Mannheim, Germany) for 1.5 h. Purple reaction product was indicative for hPAP activity of recipient-derived cells. Kidney sections and bone marrow smears from Fischer F-344wt rats served as negative controls for enzymatic staining.
Immunofluorescence double staining. For detection of donor-derived endothelium, indirect double immunostaining for RECA-1 and hPAP expression was performed. The endothelial marker RECA-1 was detected by the murine monoclonal IgG 1 antibody (AbD Serotec, Oxford, UK). For CD45 and hPAP indirect double immunostaining, a purified mouse anti-rat CD45 antibody (clone OX-1; BD Pharmingen) was used. Red fluorochrome-labeled secondary antibody was always a highly cross-adsorbed Alexa Fluor 555 goat anti-mouse monoclonal IgG antibody (Invitrogen, Pailey, UK). Primary antibody for hPAP staining was a polyclonal IgG rabbit antibody (AbD Serotec). Secondary antibody was an affinity-purified biotinylated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA). After addition of streptavidin-horseradish peroxidase (SA-HRP), a Fluorescein Tyramide Signal Amplification System (TSA; PerkinElmer, Waltham, MA) was used for green visualization of HRP activity. In a last step, cellular nuclei were stained blue with 4=,6-diamidino-2-phenylindole (DAPI). For all antibodies, negative controls consisted of substitution of the primary antibody with equivalent concentrations of an irrelevant murine monoclonal antibody or normal rabbit IgG. Untreated R26-hPAP transgenic Fischer F-344 rat kidney sections served as positive controls for double immunofluorescence sample staining of RECA-1 (red color) and hPAP (TSA amplified, green color). Specific staining patterns with yellow overlay for glomerular as well as peritubular capillaries demonstrated a high-sensitive detection system for recipient-derived endothelium (Fig. 2, A and E). Untreated F-344wt rat kidney sections were used as negative staining controls. Negativity for green hPAP signal ruled out unspecific anti-hPAP antibody binding (Fig. 2, C and G) .
Image acquisition. The technical setup included a Keyence BZ-9000 microscope for light as well as fluorescence microscopy. Digital image acquisition was performed with the built-in camera of the microscope. Glomerular images were obtained using a ϫ40 objective, whereas images of peritubular capillaries were obtained with a ϫ20 objective. Exposure times for blue, green, and red fluorescence channels as well as exposure time for light microscopy were manually set with the help of appropriate staining controls. The digitalized images were stored in uncompressed TIFF format (1,360 ϫ 1,024 pixels, 8 bit per color) for later analysis. For each biopsy, 25 consecutive cross sections of cortical glomeruli and 25 visual fields of peritubular capillary area were digitally photographed and stored. Sections of the glomerular tuft, in which the capillary cross sections had a very low cellularity, were excluded from the image acquisition.
Image analysis with Adobe Photoshop. Adobe Photoshop (version 9) allows the sampling of the color of any individual pixel and its setting as a target color. The "Select/Color Range" tool selects all pixels in the image having a color similar to that of the target color, which then can be counted with the "Histogram" tool (14) . Target colors of enzymatic hPAP staining (purple), immunohistochemical RECA-1 staining (brown), as well as immunofluorescence double staining for RECA-1 (red) and hPAP (green, yellow overlay) were defined by use of appropriate staining controls (Fig. 2 , B and F: positive control of RECA-1 and hPAP double immunostaining; Fig. 2 , D and H: negative control of RECA-1 and hPAP double immunostaining). For glomerular image analysis (25 images per biopsy, magnification ϫ40), selection of glomerular cross section area was executed by encircling the bowman capsule with the "Ellipse Selection" tool. Pixels of the staining-specific glomerular target color were counted as described above and divided by the whole glomerular pixel count. Further multiplication with 100 resulted in the glomerular percentage of the corresponding target molecule expression. Pure tubulointerstitial image area (25 images per biopsy, magnification: ϫ20) was selected with the help of the "Reverse Selection" tool where all glomeruli of the image had been selected with the "Ellipse Selection" tool in a previous step. Similar to the glomerular analysis, pixels of the staining-specific tubulointerstitial target color were counted and divided by the whole tubulointerstitial area pixel count. Statistical analysis. All values are expressed as means Ϯ SD. After testing for normality with the Shapirow-Wilk normality test, statistical significance (defined as P Ͻ 0.05) was evaluated by means of a Student's t-test. The plots were drawn with the aid of the GraphPad Prism software.
Miscellaneous measurements. Serum creatinine was measured using picric acid (Jaffé method; WAK-Chemie, Steinbach, Germany).
RESULTS
Development of kidney function after acute and chronic endothelial injury.
To investigate acute primary endothelial injury, we used the GEN model induced by an endothelial-specific antibody at first. During pilot testing of the GEN group, recipient rats died 3 days after transplantation from acute kidney failure. Therefore, we changed the experimental design so that one recipient kidney remained in place until 1 wk before the end of the final experiment. After explantation of this uninjured kidney at week 3, both GEN rats and controls did well and had normal urinary excretion. Analysis of serum creatinine at week 4 showed only a nonsignificant trend of higher serum creatinine in GEN rats indicating the recovery of the kidney function (0.65 Ϯ 0.32 mg/dl in controls, n ϭ 6, vs. 0.84 Ϯ 0.61 mg/dl in GEN rats, n ϭ 7, NS). In contrast, there was an anticipated elevation of serum creatinine in the 5/6 Nx group at the end of the experiment on the investigation of secondary endothelial injury with chronic disease progression (week 14: 0.80 Ϯ 0.38 mg/dl in controls, n ϭ 5, vs. 2.03 Ϯ 0.75 mg/dl in 5/6 Nx rats, n ϭ 5, P Ͻ 0.01).
Histologic changes after induction of GEN model and 5/6 Nx. Histology of the kidney was examined by PAS staining (images not shown). At day 3 after GEN model induction, severe kidney injury was documented. Glomerular capillaries were distorted and dense PAS-positive material was deposited in the glomerular capillary lumina. Peritubular capillaries could hardly be identified and concomitant tubular damage was prominent. At week 4, PAS staining of GEN-induced rats showed almost a complete recovery of tubular architecture with distinct peritubular capillaries. Glomerular tufts were reconstituted and only sparse residual PAS-positive material was seen.
Parallel to the kidney function, marked glomerular sclerosis and peritubular fibrosis were evident after 14 wk in the 5/6 Nx group. Glomerular tufts were dilated and peritubular capillaries were rarefied.
Endothelial rarefaction after acute primary and chronic secondary injury. At GEN day 3, immunohistochemical staining of RECA-1 was negative in a substantial part of the kidney (Fig. 3A) compared with the controls (Fig. 3B) indicating very severe acute injury to the renal endothelium. Analysis of RECA-1 expression revealed an 85% reduction within glomeruli (Fig. 3G, 6 .81 Ϯ 7.17% in GEN rats, n ϭ 7, vs. 41.20 Ϯ 6.40% in controls, n ϭ 6, P Ͻ 0.05) and a 69% reduction in the peritubular capillaries (Fig. 3H, 1 .93 Ϯ 0.74% in GEN rats, n ϭ 7, vs. 6.27 Ϯ 0.80% in controls, n ϭ 6, P Ͻ 0.05) of GEN treated rats. Nevertheless, immunohistochemical staining for RECA-1 showed an almost complete reconstitution of glomerular as well as peritubular endothelium at GEN model week 4 (Fig. 3C) . Compared with the controls (Fig. 3D) , analysis of RECA-1 expression showed no differences in both glomeruli (Fig. 3G, 30 .23 Ϯ 5.37% in GEN rats, n ϭ 7, vs. 38.22 Ϯ 6.63% in controls, n ϭ 6, NS) and peritubular capillaries (Fig.   3H , 5.02 Ϯ 1.20% in GEN rats, n ϭ 7, vs. 5.75 Ϯ 0.63% in controls, n ϭ 6, NS) of GEN-treated rats at week 4.
At 5/6 Nx week 14, immunohistochemical staining for RECA-1 demonstrated an obvious rarefication of peritubular endothelium (Fig. 3E ) compared with the controls (Fig. 3F) . For glomerular endothelium, only a trend of reduced RECA-1 expression was seen (Fig. 3G) . Analysis of RECA-1 expression showed a 49% reduction in the peritubular capillaries (Fig. 3H,  2 .43 Ϯ 1.86% in 5/6 Nx rats, n ϭ 5, vs. 4.79 Ϯ 1.34% in controls, n ϭ 5, P Ͻ 0.01) and a 23% reduction in the glomeruli (Fig. 3G, 24 .90 Ϯ 9.57% in 5/6 Nx rats, n ϭ 5, vs. 32.29 Ϯ 10.11% in controls, n ϭ 5, NS) of 5/6 Nx rats.
Results of immunohistochemical staining using the monoclonal antibody JG-12 as an endothelial cell marker highly correlated with immunohistochemical staining for RECA-1 and confirmed substantial loss of kidney endothelium after induction of the GEN as well as the 5/6 Nx injury model (data not shown).
Tracing of extrarenal hPAP ϩ cells in GEN and 5/6 Nx model. As expected, NBT/BCIP staining of R26-hPAP transgenic Fischer F-344 rat bone marrow smear preparations showed a uniform hPAP expression on all bone marrow cells, whereas Fischer F-344wt rat bone marrow smear preparations were completely hPAP negative (pictures not shown).
At GEN day 3, NBT/BCIP staining of hPAP detected only few hPAP ϩ cells in the control group (Fig. 4B ) but revealed an extensive hPAP ϩ cellular infiltrate in glomeruli and tubulointerstitium of the GEN group (Fig. 4A) . Therefore, the analysis of hPAP expression resulted in a Ͼ200-fold higher hPAP ϩ glomerular infiltrate (Fig. 4G, 23 .39 Ϯ 9.29% in GEN rats, n ϭ 7, vs. 0.11 Ϯ 0.01% in controls, n ϭ 6, P Ͻ 0.001) and a ϩ cells in the glomeruli and the tubulointerstitium. G and H: y-axis shows analysis of relative hPAP expression in percent (comparison with controls, *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001). G: glomerular hPAP expression was significantly higher at GEN day 3 (P Ͻ 0.001), GEN week 4 (P Ͻ 0.01), and 5/6 Nx week 14 (P Ͻ 0.05). H: tubulointerstitial hPAP expression was significantly higher at GEN day 3 (p Ͻ 0.001), GEN week 4 (P Ͻ 0.001), and 5/6 Nx week 14 (p Ͻ 0.01).
Ͼ100-fold higher hPAP
ϩ tubulointerstitial infiltrate (Fig. 4H,  10 .62 Ϯ 2.91% in GEN rats, n ϭ 7, vs. 0.09 Ϯ 0.03% in controls, n ϭ 6, P Ͻ 0.001) of GEN-treated rats.
At GEN week 4, NBT/BCIP staining of hPAP apparently declined in glomeruli but persisted in the tubulointerstitium (Fig. 4C) . Some hPAP ϩ cells were frequently seen in the control group (Fig. 4D) . Analysis of hPAP expression showed only a twofold higher hPAP ϩ infiltrate in glomeruli (Fig. 4G,  0 .49 Ϯ 0.39% in GEN rats, n ϭ 7, vs. 0.21 Ϯ 0.16% in controls, n ϭ 6, NS) and still a sevenfold higher hPAP ϩ infiltrate in the tubulointerstitium (Fig. 4H, 7 .76 Ϯ 2.49% in GEN rats, n ϭ 7, vs. 1.15 Ϯ 0.77% in controls, n ϭ 6, NS) of GEN-treated rats.
At 5/6 Nx week 14, NBT/BCIP staining of hPAP ϩ cells was a common finding in glomeruli of controls but was more frequent in glomeruli of 5/6 Nx rats. There was also a remarkable, focally accentuated, hPAP ϩ tubulointerstitial infiltrate that was not observed in the controls (Fig. 4, E and F) . Analysis of hPAP expression showed a fivefold higher hPAP ϩ glomerular infiltrate (Fig. 4G, 6 .42 Ϯ 5.68% in 5/6 Nx rats, n ϭ 5, vs. 1.37 Ϯ 0.88% in controls, n ϭ 5, P Ͻ 0.05) and a fivefold higher hPAP ϩ tubulointerstitial infiltrate (Fig. 4H, 23 .45 Ϯ 11.36% in 5/6 Nx rats, n ϭ 5, vs. 4.54 Ϯ 1.62% in controls, n ϭ 5, NS) of 5/6 Nx rats compared with control animals.
Endothelial recovery by extrarenal cells. Double positivity for RECA-1 and hPAP in relation to the respective RECA-1 positivity was analyzed in three GEN-induced R26-hPAP transgenic Fischer F-344 rat donor kidneys that were transplanted into R26-hPAP transgenic Fischer F-344 recipient rats to define the maximum possible sensitivity for the detection of hPAP ϩ endothelium after endothelial recovery at GEN week 4 (positive controls). Compared with the analysis of 10 untreated R26-hPAP transgenic Fischer F-344 kidneys (positive staining controls), sensitivity for the detection of glomerular hPAP ϩ endothelium in GEN-induced R26-hPAP transgenic Fischer F-344 rat kidney grafts at week 4 was reduced by 30% (51 Ϯ 35% in GEN-induced R26-hPAP kidneys, n ϭ 3, vs. 73 Ϯ 26% in untreated R26-hPAP kidneys, n ϭ 10), whereas sensitivity for detection of peritubular hPAP ϩ endothelium was reduced by 29% (50 Ϯ 37% in GEN-induced R26-hPAP kidneys, n ϭ 3, vs. 70 Ϯ 29% in untreated R26-hPAP kidneys, n ϭ 10).
RECA-1 and hPAP double immunostaining of Fischer F-344wt control kidneys showed no overlay in the glomerular as well as in the peritubular capillaries, since hPAP staining was completely negative (indicating 100% specificity).
Detection of recipient-derived endothelial cells, as defined by RECA-1 and hPAP double positivity, was a very rare finding at GEN week 4 and 5/6 Nx week 14 within the glomeruli (Fig. 5, A-D) . It was most often observed at GEN week 4 and least often in the control animals after transplantation. Analysis of GEN group at week 4 showed significantly more recipient-derived, extrarenal glomerular endothelial cells compared with the controls (Fig. 5E, 0 .076 Ϯ 0.159% in GEN rats, n ϭ 7, vs. 0.013 Ϯ 0.045% in controls, n ϭ 6, P Ͻ 0.001). Calculation of endothelial chimerism resulted in only 0.25% of recipient derived endothelium at GEN week 4 ( Fig. 5F ) and 0.03% in the respective controls. Although less frequent than in the GEN group, significantly more glomerular endothelium was recipient-derived in the 5/6 Nx group at week 14 than in the controls (Fig. 5E, 0 .012 Ϯ 0.021% in 5/6 Nx rats, n ϭ 5, vs. 0.001 Ϯ 0.003% in controls, n ϭ 5, P Ͻ 0.01). Chimerism calculation showed only 0.05% of recipient-derived glomerular endothelium at 5/6 Nx week 14 ( Fig. 5F ) and 0.003% in the associated controls. The glomerular endothelial chimerism of the GEN group was therefore fivefold higher than that of the 5/6 Nx group. Detection of peritubular endothelial cells, originating from extrarenal sources, was also a rare finding (Fig. 6,  A-D) . It was most often observed at 5/6 Nx week 14 and least often in the controls. Analysis of the 5/6 Nx group at week 14 showed a significant increase in the number of recipientderived peritubular endothelial cells compared with the controls, in contrast to the nonsignificant changes of glomerular endothelium (Fig. 6E, 0 .021 Ϯ 0.024% in 5/6 Nx rats, n ϭ 5, vs. 0.001 Ϯ 0.001% in controls, n ϭ 5, P Ͻ 0.05). Chimerism calculation resulted in 0.86% of recipient-derived endothelium in the 5/6 Nx group after 14 wk (Fig. 6F) and 0.01% in the respective control group. Analysis of the GEN group after 4 wk showed an increase of recipient-derived peritubular endothelial cells compared with the controls, which did not reach statistical significance (Fig. 6E, 0 .004 Ϯ 0.021% in GEN rats, n ϭ 7, vs. 0.001 Ϯ 0.005% in controls, n ϭ 6, NS). Chimerism calculation resulted in only 0.1% of recipient-derived peritubular endothelium at GEN week 4 ( Fig. 6F ) and 0.02% in the controls.
DISCUSSION
The role and importance of endothelial precursor cells from nonrenal sources are controversial as discussed (3, 4) . Therefore, we aimed to quantify the incorporation of endothelial cells from nonrenal vs. renal sources after primary selective ablation of kidney endothelium in the GEN model as well as after 5/6 renal mass reduction in a model of secondary endothelial injury. For that purpose, each model was combined with transplantation of Fischer F-344wt rat kidney grafts into R26-hPAP transgenic Fischer F-344 recipient rats for sensitive and reliable detection of incorporated extrarenal-derived hPAP ϩ cells. Analysis of R26-hPAP transgenic Fischer F-344 rat bone marrow smears revealed complete hPAP positivity of all bone marrow cells. We therefore assumed that putative bone marrow-derived endothelial cells could also be traced by specific hPAP staining. To maximize the chances of endothelial repair from outside the injured kidney, we purposely enhanced endothelial injury in the GEN model by increasing the antibody dose to the point whereupon on day 3 85% of the glomerular endothelial cells and 69% of the peritubular endothelium had disappeared and transplanted rats would not survive without a remaining intact kidney. GEN injury and repair in this model were therefore maximized but still did not prevent an almost complete regeneration of the kidney endothelium within 4 wk as indicated by renal function and histology. In contrast to the chronic progressive 5/6 Nx model, endothelial rarefaction was marked in peritubular capillaries after 14 wk (-49%) and less severe in glomeruli (Ϫ23%). Enzymatic hPAP activity revealed a large hPAP ϩ cellular infiltrate with a maximum at GEN day 3 (23.4% of glomeruli and 10.6% of tubulointerstitium) and at 5/6 Nx week 14 (6.5% of glomeruli and 23.5% of tubulointerstitium). Detailed characterization of hPAP ϩ cells was not an aim of our study, but others have shown that inflammatory cell types like ED-1-positive macrophages constitute the main infiltrating cell population in the GEN as well as in the 5/6 Nx model (16, 28) . This was also verified by our own results (data not shown). For detection of extrarenalderived endothelium, RECA-1 and hPAP (TSA amplified) double immunostaining was performed. We are aware that the hPAP-marker has not been used as commonly as enhanced green fluorescent protein (eGFP) or ␤-galactosidase (␤-gal) in previous studies. Nevertheless, sensitivity of hPAP detection should be equivalent to ␤-gal detection in antibody-based immunofluorescence histology. Whereas eGFP has the advantage of being directly visible during fluorescence microscopy, the feature of being enzymatically active (like hPAP or ␤-gal) during immunohistochemistry is lacking. The comparison of our results to positive control experiments (GEN-induced R26-hPAP ϩ transgenic Fischer F-344 rat donor kidneys were transplanted into R26-hPAP ϩ transgenic Fischer F-344 recipient rats) and the use of positive (untreated R26-hPAP transgenic kidney sections) as well as negative (untreated wild type Fischer F-344 rat kidney sections) staining controls demonstrate that hPAP served as a very suitable marker protein for our study. Hereby, we found a GEN-induced downregulation of endothelial hPAP expression in both glomerular (Ϫ30%) as well as peritubular capillaries (Ϫ29%) after endothelial regeneration at GEN week 4 when compared with untreated R26-hPAP transgenic Fischer F-344 rat donor kidneys. We therefore determined reliable detection of RECA-1 and hPAP coexpression after recovery from endothelial damage on the one hand (50% sensitivity) and background noise-adjusted image exposure times for the exclusion of false positive results on the other hand (100% specificity). All samples were assessed by computerized image analysis whereupon observer-based and subjective errors were excluded.
Despite substantial renal endothelial damage as well as abundant infiltration of cells with extrarenal origin were detected, only a minority of the glomerular (0.25% at GEN week 4 and 0.05% at 5/6 Nx week 14) and the peritubular endothelium (0.1% at GEN week 4 and 0.86% at 5/6 Nx week 14) was recipient derived. Even if corrected for the technical sensitivity of our RECA-1/hPAP double immunostaining of ϳ50%, the result of a very minor fraction of extrarenal replacement of the renal endothelium remains. Therefore, independently of disease type (acute or chronic) or disease outcome (healing or progression), incorporation of extrarenal precursor cells into the kidney endothelial cell layer was a rare event in our experiment. Additional double immunostaining for CD45 and hPAP revealed that at GEN week 4 as well as at 5/6 Nx week 14, almost all glomeruli were CD45 negative whereas almost all peritubular CD45 ϩ cells were hPAP ϩ (data not shown). We therefore speculate that incorporated RECA-1 and hPAP double-positive cells might be true endothelial progenitor cells lacking CD45 expression although this explanation is speculative and only suggested by the negative results of our glomerular CD45 and hPAP double immunostaining (17) . In a similar experimental setup, Rienstra et al. (22) transplanted dark Aagouti rat kidneys into R26-hPAP transgenic Fischer F-344 recipient rats to induce allogeneic chronic transplant vasculopathy. In contrast to our results, 62% of all glomeruli contained recipient-derived endothelial cells 12 wk after transplantation. Recipient endothelial chimerism was furthermore observed at low levels in peritubular capillaries (22) . Major methodological differences between the study of Rienstra and our study are unlikely since an analogous immunostaining technique for hPAP ϩ kidney endothelium was used. Although there is the question why no images of TSA amplified hPAP staining controls were published, the fact that the underlying pathomechanisms of chronic allograft vasculopathy are distinct and hardly comparable with the situation of renal endothelial repair during kidney diseases in a syngeneic situation may be most important. Xu et al. (27) detected even Ͼ30% of recipient-derived endothelium on day 20 after transplantation of ischemic male Brown Norway rat kidneys into female Lewis rats. In this study, recipient-derived cells were identified by X-chromosome specific DNA samples but double staining with an endothelial marker was not performed.
Overall, analysis at different time points as well as methodological and sensitivity differences in the detection of endothelial chimerism make a comparison of results in rodents or even humans after kidney transplantation quite difficult. For example, several groups analyzed endothelial chimerism after human sex-mismatched kidney transplantation with in situ hybridization. Results ranged from 17.5% to the detection of no endothelial chimerism at all and therefore may be indicative for sensitivity issues of this method (1, 10, 25) . Other groups used experimental transplantation of allogeneic or transgenic bone marrow (e.g., eGFP and ␤-gal) for the detection of bone marrow-derived renal endothelium after kidney injury. Conflicting results ranged from seven donor-derived endothelial cells per glomerular cross section to the detection of no endothelial chimerism at all (9, 12, 13, 23) . We are convinced that experimental kidney transplantation is more suitable for investigation of renal endothelial cell chimerism since whole bone marrow transplantation results in transfer of both putative endothelial progenitor cells and also mature endothelial cells of the bone marrow cavity. In addition, the process of bone marrow transplantation takes ϳ6 wk and allows infiltration or incorporation of recipient-derived cells before disease model induction. Nevertheless, the rare event of incorporation of extrarenalderived cells into renal endothelium as demonstrated in our experiments using very severe and chronic progressive endothelial injury models does not mean that these cells are not important for renal injury repair. However, this result suggests that extrarenal-derived cell recruitment contributes rather indirectly via paracrine effects to kidney endothelial healing than through plain incorporation into the endothelial layer as supported by studies from other groups. For example, during tumor angiogenesis abundant bone marrow-derived cells are recruited close to endothelial cells but did not form part of the endothelium (20) . In addition, it has been shown that recruited bone marrow-derived cells can enhance capillary repair and angiogenesis by in situ proliferation of endothelial cells via secretion of proangiogenic factors (7), by expression of several chemokines at growing sites of collateral arteries (29) , or by transfer of membrane-derived mRNAcontaining microvesicles (6) .
In summary, independently of the type and time course of disease (acute vs. chronic progressive) and despite marked severity of renal endothelial cell injury, endothelial regeneration originated almost exclusively from intrinsic kidney cells. While many extrarenal recipient-derived cells were transiently recruited to the injured kidney, the incorporation of endothelial precursor cells into the renal endothelial layer was increased but still a rare event with Ͻ1% of all endothelial cells. Recently, therapeutic transfer of cultured endothelial progenitor cells has been effective in ameliorating pathologic kidney changes owing to experimental 5/6 renal mass reduction of the mice and experimental renal arterial stenosis of the swine (5, 24) . This suggests that endothelial precursor cells act mostly by exerting paracrine effects. Based on these promising findings and our own results, future research should focus on the probably paracrine interactions between endothelial progenitor cells and renal endothelium to further unravel the mechanisms that lead to kidney regeneration.
